Samsara BioCapital’s Astria Therapeutics ATXS Stock Holding History

Samsara BioCapital’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$208K	–	42
2023 Q2	$208K	Hold	25,000	–	–	0.04%	42
2023 Q1	$333K	Hold	25,000	–	–	0.07%	44
2022 Q4	$372K	Hold	25,000	–	–	0.08%	47
2022 Q3	$226K	Hold	25,000	–	–	0.05%	52
2022 Q2	$75K	Hold	25,000	–	–	0.02%	55
2022 Q1	$168K	Hold	25,000	–	–	0.04%	56
2021 Q4	$135K	Hold	25,000	–	–	0.03%	50
2021 Q3	$221K	Hold	25,000	–	–	0.04%	47
2021 Q2	$317K	Hold	25,000	–	–	0.04%	49
2021 Q1	$434K	Sell	25,000 -25,000	-50%	-$452K	0.09%	43
2020 Q4	$642	Hold	50,000	–	–	0.06%	41
2020 Q3	$1.86M	Hold	50,000	–	–	0.52%	29
2020 Q2	$1.93M	Hold	50,000	–	–	0.62%	25
2020 Q1	$1.25M	Hold	50,000	–	–	0.72%	23
2019 Q4	$1.77M	Hold	50,000	–	–	0.85%	19
2019 Q3	$1.62M	Hold	50,000	–	–	1.1%	13
2019 Q2	$2.42M	Hold	50,000	–	–	1.6%	13
2019 Q1	$2.38M	Hold	50,000	–	–	1.87%	12
2018 Q4	$1.31M	Buy	+50,000	New	+$1.89M	1.26%	12

Other funds holding ATXS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Altium Capital Management New York $42M AUM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return